Therapeutic strategies for human microsporidia infections

Expert Review of Anti-Infective Therapy

Volumn 3, Issue 3, 2005, Pages 419-434

  Didier, Elizabeth S ^a   Maddry, Joseph A ^b   Brindley, Paul J ^a   Stovall, Mary E ^c   Didier, Peter J ^c  

^a TULANE UNIVERSITY   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

Albensdazole; Emerging infection; Encephalitozoon; Enterocytozoon; Fumagillin; Opportunistic infection; Zoonosis

Indexed keywords

ALBENDAZOLE; ANGIOGENESIS INHIBITOR; ANTIFUNGAL AGENT; ANTIPROTOZOAL AGENT; ANTIRETROVIRUS AGENT; ATOVAQUONE; BENZIMIDAZOLE; CALCIUM CHANNEL BLOCKING AGENT; CALMODULIN INHIBITOR; CHITIN; CHLORPROMAZINE; CLINDAMYCIN; CLOTRIMAZOLE; DNA TOPOISOMERASE; FOLINIC ACID; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE; FURAZOLIDONE; GATIFLOXACIN; ITRACONAZOLE; LANTHANUM; LOMEFLOXACIN; LUFENURON; METHIONYL AMINOPEPTIDASE; METRONIDAZOLE; NIFEDIPINE; NIKKOMYCIN; NIKKOMYCIN Z; NITAZOXANIDE; NORFLOXACIN; OFLOXACIN; OVALICIN; PEFLOXACIN; POLYAMINE DERIVATIVE; POLYOXIN D; PROTEINASE INHIBITOR; PUTRESCINE; PYRIMETHAMINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR; SPARFLOXACIN; SPERMIDINE; SPERMINE; SULFADIAZINE; THALIDOMIDE; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; VERAPAMIL;

DIARRHEA; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; ENCEPHALITOZOON; FEVER; HUMAN; MICROSPORIDA; MICROSPORIDIOSIS; NEUTROPENIA; NONHUMAN; PROGRAM; REVIEW; SIDE EFFECT; SYSTEMIC DISEASE; THROMBOCYTOPENIA; WEIGHT REDUCTION;

ANTIFUNGAL AGENTS; COMMUNICABLE DISEASES, EMERGING; HUMANS; MICROSPORIDIOSIS; MOLECULAR STRUCTURE;

EID: 21044436811     PISSN: 14787210     EISSN: None     Source Type: Journal    
DOI: 10.1586/14787210.3.3.419     Document Type: Review

References (192)

1. Vossbrinck CR, Maddox JV, Friedman S, Debrunner-Vossbrinck BA, Woese CR. Ribosomal RNA sequence suggests microsporidia are extremely ancient eukaryotes. Nature 326, 411-414 (1987).
2. Edlind TD, Li J, Visvesvara GS, Vodkin MH, McLaughlin GL, Katiyar SK. Phylogenetic analysis of β-tubulin sequences from amitochondrial protozoa. Mol. Phylogenet. Evol. 5, 359-367 (1996).
3. Cavalier-Smith T. A revised six-kingdom system of life. Biol. Rev. Camb. Philos. Soc. 73, 203-266 (1998).
4. Weiss LM, Vossbrinck CR. Molecular biology, molecular phylogeny, and molecular diagnostic approaches to the microsporidia. In: The Microsporidia and Microsporidiosis. Wittner M, Weiss LM (Eds), American Society for Microbiology, WA, USA, 129-171 (1999).
5. Weiss LM, Edlind TD, Vossbrinck CR, Hashimoto T. Microsporidian molecular phylogeny: the fungal connection. J. Eukaryot. Microbiol. 46, 17S-18S (1999).
6. Vossbrinck CR, Andreadis TG, Weiss LM. Phylogenetics: taxonomy and the microsporidia as derived fungi. In: Opportunistic Infections: Toxoplasma, Sarcocystis, and Microsporidia. Lindsay DS, Weiss LM (Eds), Kluwer Academic Publishers, NA, USA, 189-213 (2004).
7. Wittner M. Historic perspective on the microsporidia: expanding horizons. In: The Microsporidia and Microsporidiosis. Wittner M, Weiss LM (Eds), American Society for Microbiology, WA, USA, 1-6 (1999).
8. Desportes I, Le Charpentier Y, Galian A. et al. Occurrence of a new microsporidan: Enterocytozoon bieneusi n.g., n. sp., in the enterocytes of a human patient with AIDS. J. Protozool. 32, 250-254 (1985).
9. Bryan RT, Schwartz DA. Epidemiology of microsporidiosis. In: The Microsporidia and Microsporidiosis. Wittner M, Weiss LM (Eds), American Society for Microbiology, WA, USA, 502-516 (1999).
10. Schwartz DA, Bryan RT. Microsporidial infections: progress in epidemiology and prevention. In: Emerging Infections (Volume 3). Scheld WM, Craig RM, Hughes JM (Eds), American Society for Microbiology, WA, USA, 73-98 (1999).
11. Deplazes P, Mathis A, Weber R. Epidemiology and zoonotic aspects of microsporidia of mammals and birds. Contrib. Microbiol. 6, 236-260 (2000).
12. Didier ES, Stovall ME, Green LC, Brindley PJ, Sestak K, Didier PJ. Epidemiology of microsporidiosis: sources and modes of transmission. Vet. Parasitol. 126, 145-166 (2004).
13. Vavra J, Larsson R. Structure of the microsporidia. In: The Microsporidia and Microsporidiosis. Wittner M, Weiss LM (Eds), American Society for Microbiology, WA, USA, 7-84 (1999).
14. Desportes-Livage I. Biology of microsporidia. Contrib. Microbiol. 6, 140-165 (2000).
15. Canning EU, Vavra J. Phylum microsporidia. in: The Illustrated Guide to the Protozoa (2nd Edition). Lee JJ, Leedale GF, Bradbury PB (Eds), Society of Protozoologists, KS, USA, 39-126 (2000).
16. Biderre C, Mathis A, Deplazes P, Weber R, Méténier G, Vivarès CP. Molecular karyotype diversity in the microsporidian Encephalitozoon cuniculi. Parasitology 118, 439-445 (1999).
17. Katinka MD, Duprat S, Cornillot E et al. Genome sequence and gene compaction of the eukaryote parasite Encephalitozoon cuniculi. Nature 414, 450-453 (2001).
18. Williams BA, Hirt R, Lucocq JM, Embley TM. A mitochondrial remnant in the microsporidian Trachipleistophora hominis. Nature 418, 865-869 (2002).
19. Slamovits CH, Fast NM, Law JS, Keeling PJ. Genome compaction and stability in microsporidian intracellular parasites. Curr. Biol. 14, 891-896 (2004).
20. Vivarès CP, Méténier G. The microsporidia genome: living with minimal genes as an intracellular eukaryote. In: Opportunistic Infections: Toxoplasma, Sarrocystis, and Microsporidia. Lindsay DS, Weiss LM (Eds), Kluwer Academic Publishers, NA, USA, 215-242 (2004).
21. Takvorian PM, Cali A. Enzyme histochemical identification of the Golgi apparatus in the microsporidian, Glugea stephani. J. Eukaryot. Microbiol. 41, 63S-64S (1994).
22. Sokolova Y, Snigirevskaya E, Morzhina E, Skarlato S, Mironov A, Komissarchik Y. Visualization of early Golgi compartments at proliferate and sporogenic stages of a microsporidian Nosema grylli. J. Eukaryot. Microbiol. (Suppl.), 86-87 (2001).
23. Weidner E, Findley A. Catalase in microsporidian spores before and during discharge. Biol. Bull. 205, 236-237 (2003).
24. Didier ES, Snowden KF, Shadduck JA. Biology of microsporidian species infecting mammals. Adv. Parasitol. 40, 283-320 (1988).
25. Didier ES, Didier PJ, Snowden KF, Shadduck JA. Microsporidiosis in mammals. Microb. Infect. 2, 709-720 (2000).
26. Cali A, Takvorian PM. Ultrastructure and 2development of Pleistophora ronneafiei n. sp., a microsporidium (Protista) in the skeletal muscle of an immune-compromised individual. J. Eukaryot. Microbiol. 50, 77-85 (2003).
27. Keohane EM, Weiss LM. The structure, function, and composition of the microsporidian polar tube. In: The Microsporidia and Microsporidiosis. Wittner M, Weiss LM (Eds), American Society for Microbiology, WA, USA, 196-224 (1999).
28. Weidner E. Ultrastructural study of microsporidian invasion into cells. Z. Parasitenkd. 40, 227-242 (1972).
29. Undeen AH. A proposed mechanism for the germination of microspridian (Protozoa: Microspora) spores. J. Theor. Biol. 142, 223-235 (1990).
30. Kotler DP, Orenstein JM. Clinical syndromes associated with microsporidiosis. Adv. Parasitol. 40, 321-349 (1998).
31. Kotler DP, Orenstein JM. Clinical syndromes associated with microsporidiosis. In: The Microsporidia and Micraporidiosis. Wittner M, Weiss LM (Eds), American Society for Microbiology, WA, USA, 258-292 (1999).
32. Weber R, Deplazes P, Schwartz D. Diagnosis and clinical aspects of human microsporidiosis. Contrib. Microbiol. 6, 166-192 (2000).
33. Sandfort J, Hannemann A, Gelderblom H, Stark K, Owen RL, Ruf B. Enterocytozoon bieneusi infection in an immunocompetent patient who had acute diarrhea and who was not infected with the human immunodeficiency virus. Clin. Infect. Dis. 19, 514-516 (1994).
34. Thielman NM, Guerrant RL. Persistent diarrhea in the returned traveler. Infect. Dis. Clin. North Am. 12, 489-501 (1998).
35. Raynaud L, Delbac F, Broussolle V et al. Identification of Encephalitozoon intestinalis in travelers with chronic diarrhea by specific PCR amplification. J. Clin. Microbiol. 36, 37-40 (1998).
36. Okhuysen PC. Traveler's diarrhea due to intestinal protozoa. Clin. Infect. Dis. 1, 110-114 (2001).
37. Shadduck JA, Orenstein JM. Comparative pathology of microsporidiosis. Arch. Pathol. Lab. Med. 117, 1215-1219 (1993).
38. Snowden KF, Didier ES, Orenstein JM, Shadduck JA. Animal models of human microsporidial infections. Lab. Anim. Sci. 48, 589-592 (1998).
39. Van Gool T, Vetter JC, Weinmayr B, Van Dam A, Derouin F, Dankert J. High seroprevalence of Encephalitozoon species in immunocompetent subjects. J. Infect. Dis. 175, 1020-1024 (1997).
40. Cislakova L, Prokopcakova H, Stef'kovic M, Halanova M. Encephalitozoon cuniculi - clinical and epidemiologic significance. Results of a preliminary serologic study in humans. Epidemiol. Mikrobiol. Imunol. 46, 30-33 (1997).
41. Visvesvara GS, Belloso M, Moura H et al. Isolation of Nosema algerae from the cornea of an immunocompetent patient. J. Eukaryot. Microbiol. 46, 10S (1999).
42. Coyle CM, Weiss LM, Rhodes LV III et al. Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen. N. Engl. J. Med. 351, 42-47 (2004).
43. Margileth AM, Strano AJ, Chandra R, Neafie R, Blum M, McCully RM. Disseminated nosematosis in an immunologically compromised infant. Arch. Pathol. 95, 145-150 (1973).
44. Cali A, Takvorian PM, Lewin S et al. Brachiola vesicularum, n. g., n. sp., a new microsporidium associated with AIDS and myositis. J. Eukaryot. Microbiol. 45, 240-251 (1998).
45. Pinnolis M, Egbert PR, Font RL, Winter FC. Nosematosis of the cornea. Case report, including electron microscopic studies. Arch. Ophthalmol. 99, 1044-1047 (1981).
46. Ashton N, Wirasinha PA. Encephalitozoonosis (nosematosis) of the cornea. Br. J. Ophthalmol. 57, 669-674 (1973).
47. Canning EU, Lom J. The Microsporidia of Vertebrates. Academic Press, NY, USA, 1-289 (1986).
48. Bryan R, Cali A, Owen R, Spencer H. Microsporidia: newly recognized opportunistic pathogens in patients with AIDS. In: Progress in Clinical Parasitology Sun T (Ed.), WW Norton and Co., Publishers, NY, USA, 1-26 (1990).
49. Cali A, Meisler DM, Lowder CY et al. Corneal microsporidioses: characterization and identification. J. Protozool. 38, 215S-217S (1991).
50. Ledford DK, Overman MD, Gonzalvo A, Cali A, Mester SW, Lockey RF. Microsporidiosis myositis in a patient with the acquired immunodeficiency syndrome. Ann. Intern. Med. 102, 628-630 (1985).
51. Cali A, Takvorian PM. Ultrastructure and development of Pleistophora ronneafiei n. sp., a microsporidium (Protista) in the skeletal muscle of an immune-compromised individual. J. Eukaryot. Microbiol. 50, 77-85 (2003).
52. Yachnis AT, Berg J, Martinez-Salazar A et al. Disseminated microsporidiosis especially infecting the brain, heart, and kidneys. Report of a newly recognized pansporoblastic species in two symptomatic AIDS patients. Am. J. Clin. Pathol. 106, 535-543 (1996).
53. Vavra J, Yachnis AT, Shadduck JA, Orenstein JM. Microsporidia of the genus Trachipleistophora - causative agents of human microsporidiosis: description of Trachipleistophora anthropophthera n. sp. (Protozoa: Microsporidia). J. Eukaryot. Microbiol. 45, 273-283 (1998).
54. Juarez SI, Ichinose A, Jongwutiwes S, Yanagi T, Kanbara H. A species of microsporidium isolated from an HIV-infected patient and identified as Trachipleistophora anthropophthera by transmission electron microscopy. J. Eukaryot. Microbiol. 50(S), 576 (2003).
55. Field AS, Marriott DJ, Milliken ST et al. Myositis associated with a newly described microsporidian, Trachipleistophora hominis, in a patient with AIDS. J. Clin. Microbiol. 34, 2803-2811 (1996).
56. Hollister WS, Canning EU, Weidner E, Field AS, Kench J, Marriott DJ. Development and ultrastructure of Trachipleistophora hominis n.g., n.sp. after in vitro isolation from an AIDS patient and inoculation into athymic mice. Parasitology 112, 143-154 (1996).
57. Rauz S, Tuft S, Dart JK, Bonshek R, Luthert P, Curry A. Ultrastructural examination of two cases of stromal microsporidial keratitis. J. Med. Microbiol. 53, 775-781 (2004).
58. Davis RM, Font RL, Keisler MS, Shadduck JA. Corneal microsporidiosis. A case report including ultrastructural observations. Ophthalmology 97, 953-957 (1990).
59. Shadduck JA, Meccoli RA, Davis R, Font RL. Isolation of a microsporidian from a human patient. J. Infect. Dis. 162, 773-776 (1990).
60. Silveira H, Canning EU. Vittaforma corneae n. comb. for the human microsporidium Nosema corneum Shadduck, Meccoli, Davis & Font, 1990, based on its ultrastructure in the liver of experimentally infected athymic mice. J. Eukaryot. Microbiol. 42, 158-165 (1995).
61. Deplazes P, Mathis A, van Saanen M et al. Dual microsporidial infection due to Vittaforma corneae and Encephalitozoon hellem in a patient with AIDS. Clin Infect Dis. 27, 1521-1524 (1998).
62. Orenstein JM, Gaetz HP, Yachnis AT, Frankel SS, Mertens RB, Didier ES. Disseminated microsporidiosis in AIDS: are any organs spared? AIDS 11, 385-386 (1997).
63. Orenstein JM, Chiang J, Steinberg W, Smith PD, Rotterdam H, Kotler DP. Intestinal microsporidiosis as a cause of diarrhea in human immunodeficiency virus-infected patients: a report of 20 cases. Hum. Pathol. 21, 475-481 (1990).
64. Orenstein JM, Tenner M, Cali A, Kotler DP. A microsporidian previously undescribed in humans, infecting enterocytes and macrophages, and associated with diarrhea in an acquired immunodeficiency syndrome patient. Hum. Pathol. 23, 722-728 (1992).
65. Cali A, Takvorian P. Developmental morphology and life cycles of the microsporidia. In: The Microsporidia and Microsporidiosis. Wittner M, Weiss LM (Eds), American Society for Microbiology, WA, USA, 85-128 (1999).
66. Garcia LS. Laboratory identification of the microsporidia. J. Clin. Microbiol. 40, 1892-1901 (2002).
67. Fedorko DP, Hijazi YM. Application of molecular techniques to the diagnosis of microsporidial infection. Emerg. Infect. Dis. 2, 183-191 (1996).
68. Franzen C, Müller A. Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia. Clin. Microbiol. Rev. 12, 243-285 (1999).
69. Weiss LM. Molecular phylogeny and diagnostic approaches to microsporidia. Contrib. Microbiol. 6, 209-235 (2000).
70. Dowd SE, Gerba CP, Enriquez FJ, Pepper IL. PCR amplification and species determination of microsporidia in formalin-fixed feces after immunomagnetic separation. Appl. Environ. Microbiol. 64, 333-336 (1998).
71. Orlandi PA, Lampel KA. Extraction-free, filter-based template preparation for rapid and sensitive PCR detection of pathogenic parasitic protozoa. J. Clin. Microbiol. 38, 2271-2277 (2000).
72. Carnevale S, Velásquez JN, Labbé JH et al. Diagnosis of Enterocytozoon bieneusi by PCR in stool samples eluted from filter paper disks. Clin. Diag. Lab. Immunol. 7, 504-506 (2000).
73. Sorel N, Guillot E, Thellier M et al. Development of an immunomagnetic separation - polymerase chain reaction (IMS-PCR) assay specific for Enterocytozoon bieneusi in water samples. J. Appl. Microbiol. 94, 273-279 (2003).
74. Subrungruang I, Mungthin M, Chavalitshewinkoon-Petmitr P, Ransin R, Naaglor T, Leelayoova S. Evaluation of DNA extraction and PCR methods for detection of Enterocytozoon bieneusi in stool specimens. J. Clin. Microbiol. 42, 3490-3494 (2004).
75. Singh M, Kane GJ, Mackinlay L et al. Detection of antibodies to Nosema cuniculi (Protozoa: Microscoporidia) in human and animal sera by the indirect fluorescent antibody technique. Southeast Asian J. Trop. Med. Public Health 13, 110-113 (1982).
76. Bergquist R, Morfeldt-Mansson L, Pehrson PO, Petrini B, Wasserman J. Antibody against Encephalitozoon cuniculi in Swedish homosexual men. Scand. J. Infect. Dis. 16, 389-391 (1984).
77. Hollister WS, Canning EU, Willcox A. Evidence for widespread occurrence of antibodies to Encephalitozoon cuniculi (Microspora) in man provided by ELISA and other serological tests. Parasitology 102(Pt 1), 33-43 (1991).
78. Van Gool T, Biderre C, Delbac F, Wentink-Bonnema E, Peek R, Vivares CP. Serodiagnostic studies in an immunocompetent individual infected with Encephalitozoon cuniculi. J. Infect. Dis. 189, 2243-2249 (2004).
79. Kucerova-Pospisilova Z, Ditrich O. The serological surveillance of several groups of patients using antigens of Encephalitozoon hellem and E. cuniculi antibodies to microsporidia in patients. Folia Parasitol (Praha) 45, 108-112 (1998).
80. Kucerova-Pospisilova Z, Secor WE, Moura H et al. An ELISA test to detect human serum antibodies reactive with Encephalitozoon intestinalis. J. Eukaryot. Microbiol. (Suppl.), 73-74 (2001).
81. del Aguila C, Rueda C, De la Camara C, Fenoy S. Seroprevalence of anti-Encephalitozoon antibodies in Spanish immunocompetent subjects. J. Eukaryot. Microbiol. (Suppl.), 75-78 (2001).
82. Curry A, Smith HV. Emerging pathogens: isospora, cyclospora and microsporidia. Parasitology 117(Suppl.), 143-159 (1998).
83. Seitz HM, Trammer T. Opportunistic infections caused by protozoan parasites. Tokai J. Exp. Clin. Med. 23, 249-257 (1998).
84. Shadduck JA, Pakes SP. Encephalitozoonosis (nosematosis) and toxoplasmosis. Am. J. Pathol. 64, 657-671 (1971).
85. Lopez-Velez R, Turrientes MC, Garron C et al. Microsporidiosis in travelers with diarrhea from the tropics. J. Travel Med. 6, 223-237 (1999).
86. Müller A, Bialek R, Kamper A, Fatkenheuer G, Salzberger B, Franzen C. Detection of microsporidia in travelers with diarrhea. J. Clin. Microbiol. 39, 1630-2632 (2001).
87. Valperga SM, de Jogna Prat SA, de Valperga GJ et al. Microsporidian spores in the stool specimens of toddlers, with or without diarrhea, from Tucuman, Argentina. Rev. Argent. Microbiol. 31, 157-164 (1999).
88. Chokephaibulkit K, Winachiwanawin D, Tosasuk K, Pavitpok J, Vanprapar N, Chearskul S. Intestinal parasitic infections among human immunodeficiency virus-infected and -uninfected children hospitalized with diarrhea in Bangkok, Thailand. Southeast Asian J. Trop. Med. Public Health 32, 770-775 (2001).
89. Mungthin M, Suwannasaeng R, Naaglor T, Areekul W, Leelayoova S. Asymptomatic intestinal microsporidiosis in Thai orphans and child-care workers. Trans. R. Soc. Trop. Med. Hyg. 95, 304-306 (2001).
90. Tumwine JK, Kekitiinwa A, Nabukeera N, Akiyoshi, DE, Buckholt MA, Tzipori S. Enterocytozoon bieneusi among children with diarrhea attending Mulago Hospital in Uganda. Am. J. Trop. Med. Hyg. 67, 299-303 (2002).
91. Winachiwanawin D, Chokephaibulkit K, Lertlaituan P, Ongrotchanakun J, Chinabut P, Thakerngpol K. Intestinal microsporidiosis in HIV-infected children with diarrhea. Southeast Asian J. Trop. Med. Public Health 33, 241-245 (2002).
92. Lores B, Lopez-Miragaya I, Arias C, Fenoy S, Torres J, del Aguila C. Intestinal microsporidiosisdue to Enterocytozoon bieneusi in elderly human immunodeficiency virus-negative patients from Vigo, Spain. Clin. Infect. Dis. 34, 918-921 (2002).
93. Birthistle K, Moore P, Hay P. Microsporidia: a new sexually transmissable cause of urethritis. Genitourin. Med. 72, 445 (1996).
94. Hutin YJ, Sombardier MN, Liguory O et al. Risk factors for intestinal microsporidiosis in patients with human immunodeficiency virus infection: a case-control study. J. Infect. Dis. 178, 904-907 (1998).
95. Dascomb K, Frazer T, Clark RA, Kissinger P, Didier ES. Microsporidiosis and HIV. J. Acquir. Immune Defic. Syndr. 24, 290-292 (2000).
96. Didier ES. Microsporidiosis: an emerging and opportunistic infection in humans and animals. Acta Trop. (2005)(In Press).
97. Slifko TR, Smith HV, Rose JB. Emerging parasite zoonoses associated with water and food. Int. J. Parasitol. 30, 1379-1393 (2000).
98. McInnes EF, Stewart CG. The pathology of subclinical infection of Encephalitozoon cuniculi in canine dams producing pups with overt encephalitozoonosis. J. S. Afr. Vet. Assoc. 62, 51-54 (1991).
99. Lowman PM, Takvorian PM, Cali A. The effects of elevated temperatures and various time-temperature combinations on the development of Brachiola (Nosema) algerae N. Comb. in mammalian cell culture. J. Eukaryot. Microbiol. 47, 221-234 (2000).
100. Avery SW, Undeen AH. The isolation of microsporidia and other pathogens from concentrated ditch water. J. Am. Mosq. Control Assoc. 3, 54-58 (1987).
101. Sparfel JM, Sarfati C, Liguory O et al. Detection of microsporidia and identification of Enterocytozoon bieneusi in surface water by filtration followed by specific PCR. J. Eukaryot. Microbiol. 44, 78S (1997).
102. Dowd SE, Gerba CP, Pepper IL. Confirmation of the human-pathogenic microsporidia, Enterocytozoon bieneusi, Encephalitozoon intestinalis, and Vittaforma corneae, in water. Appl Environ. Microbiol. 64, 3332-3335 (1998).
103. Fournier S, Liguory O, Santillana-Hayat M et al. Detection of microsporidia in surface water: a one-year follow-up study. FEMS Immunol. Med. Microbiol. 29, 95-100 (2000).
104. Fournier S, Dubrou S, Liguory O et al. Detection of Microsporidia, Cryptosporidia and Giardia in swimming pools: a one-year prospective study. FEMS Immunol. Med. Microbiol. 33, 209-213 (2002).
105. Thurston-Enriquez JA, Watt P, Dowd SE, Enriquez R, Pepper IL, Gerba CP. Detection of protozoan parasites and microsporidia in irrigation waters used for crop production. J. Food Prot. 65, 378-382 (2002).
106. Cotte L, Rabodonirina M, Chapuis F et al. Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection. J. Infect. Dis. 180, 2003-2008 (1999).
107. Sulaiman IM, Fayer R, Lal AA, Trout JM, Schaefer FW III, Xiao L. Molecular characterization of microsporidia indicates that wild mammals harbor host-adapted Enterocytozoon spp. as well as human-pathogenic Enterocytozoon bieneusi. Appl. Environ. Microbiol. 69, 4495-4501 (2003).
108. Franzen C, Müller A. Cryptosporidia and microsporidia - waterborne diseases in the immunocompromised host. Diagn. Microbiol. Infect. Dis. 34, 245-262 (1999).
109. Conteas CN, Berlin OG, Ash LR, Pruthi JS. Therapy for human gastrointestinal microsporidiosis. Am. J. Trop. Med. Hyg. 63, 121-127 (2000).
110. Lacey E. Mode of action of benzimidazoles. Parasitol. Today 6, 112-115 (1990).
111. Blanshard C, Ellis DS, Dowell SP, Tovey G, Gazzard BG. Electron microscopic changes in Enterocytozoon bieneusi following treatment with albendazole. J. Clin. Pathol. 46, 898-902 (1993).
112. Blanshard C, Ellis DS, Tovey DG, Dowell S, Gazzard BG. Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. AIDS 6, 311-313 (1992).
113. Dieterich DT, Lew EA, Kotler DP, Poles MA, Orenstein JM. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J. Infect. Dis. 169, 178-183 (1994).
114. Dore GJ, Marriott DJ, Hing MC, Harkness JL, Field AS. Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole. Clin Infect Dis. 21, 70-76 (1995).
115. Sobottka I, Albrecht H, Schafer H et al. Disseminated Encephalitozoon (Septata) intestinalis infection in a patient with AIDS: novel diagnostic approaches and autopsy-confirmed parasitological cure following treatment with albendazole. J. Clin. Microbiol. 33, 2948-2952 (1995).
116. Joste NE, Rich JD, Busam KJ, Schwartz DA. Autopsy verification of Encephalitozoon intestinalis (microsporidiosis) eradication following albendazole therapy. Arch. Pathol. Lab. Med. 120, 199-203 (1996).
117. Leder K, Ryan N, Spelman D, Crowe SM. Microsporidial disease in HIV-infected patients: a report of 42 patients and review of the literature. Scand. J. Infect. Dis. 30, 331-338 (1998).
118. Molina JM, Tourneur M, Sarfati C et al. Fumagillin treatment of intestinal microsporidiosis. N. Engl. J. Med. 346, 1963-1969 (2002).
119. Katiyar SK, Gordon VR, McLaughlin GL, Edlind TD. Antiprotozoal activities of benzimidazoles and correlations with β-tubulin sequence. Antimicrob. Agents Chemother. 38, 2086-2090 (1994).
120. Didier ES. Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro. Antimicrob. Agents Chemother. 41, 1541-1546 (1997).
121. Lafranchi-Tristem NJ, Curry A, Cheney SA, Canning EU. Growth of Trachipleistophora hominis (Microsporidia: Pleistophoridae) in C2,C12 mouse myoblast cells and response to treatment with albendazole. Folia. Parasitol. (Praha) 48, 192-200 (2001).
122. Lacey E, Gill JH. Biochemistry of benzimidazole resistance. Acta Trop. 56, 245-262 (1994).
123. Liu LX, Weller PF. Antiparasitic drugs. N. Engl. J. Med. 334, 1178-1184 (1996).
124. Tremoulet AH, Avila-Aguero ML, Paris MM, Canas-Coto A, Ulloa-Gutierrez R, Faingezicht I. Albendazole therapy for Microsporidium diarrhea in immunocompetent Costa Rican children. Pediatr. Infect. Dis. J. 23, 915-918 (2004).
125. Shah GK, Pfister D, Probst LE, Ferrieri P. Holland E. Diagnosis of microsporidial keratitis by confocal microscopy and the chromatrope stain. Am. J. Ophthalmol. 121, 89-91 (1996).
126. Teruel MT, Felipe AE, Solana HD, Sallovitz JM, Lanusse CE. Placental and fetal toxicity of albendazole sulphoxide in Wistar rats. Vet. Hum. Toxicol. 45, 131-136 (2003).
127. Franssen FF, Lumeij JT, van Knapen F. Susceptibility of Encephalitozoon cuniculi to several drugs in vitro. Antimicrob. Agents Chemother. 39, 1265-1268 (1995).
128. Didier ES, Maddry JA, Kwong CD, Green LC, Snowden KF, Shadduck JA. Screening of compounds for antimicrosporidial activity in vitro. Folia Parasitol. (Praha) 45, 129-139 (1998).
129. McCowen MC, Callender ME, Lawlis JF Jr. Fumagillin (H-3), a new antibiotic with amebicidal properties. Science 113, 202-203 (1951).
130. Katznelson H, Jamieson CA. Control of nosema disease of honeybees with fumagillin. Science 115, 70-71 (1952).
131. Killough JH, MagillGB, Smith RC. The treatment of amebiasis with fumagillin. Science 115, 71-72 (1952).
132. Shadduck JA. Effect of fumagillin on in vitro multiplication of Encephalitozoon cuniculi. J. Protozool. 27, 202-208 (1980).
133. Beauvais B, Sarfati C, Challier S, Derouin F. In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi. Antimicrob. Agents Chemother. 38, 2440-2448 (1994).
134. Coyle C, Kent M, Tanowitz HB, Wittner M, Weiss LM. TNP-470 is an effective antimicrosporidial agent. J. Infect. Dis. 177, 515-518 (1998).
135. Diesenhouse MC, Wilson LA, Corrent GF, Visvesvara GS, Grossniklaus HE, Bryan RT. Treatment of microsporidial keratoconjunctivitis with topical fumagillin. Am. J. Ophthalmol. 115, 293-298 (1993).
136. Rosberger DF, Serdarevic ON, Erlandson RA et al. Successful treatment of microsporidial keratoconjunctivitis with topical fumagillin in a patient with AIDS. Cornea 12, 261-265 (1993).
137. Wilkins JH, Joshi N, Margolis TP, Cevallos V, Dawson CR. Microsporidial keratoconjunctivitis treated successfully with a short course of famagillin. Eye 8, 703-704 (1994).
138. Garvey MJ, Ambrose PG, Ulmer JL. Topical fumagillin in the treatment of microsporidial keratoconjunctivitis in AIDS. Ann. Pharmacother. 29, 872-874 (1995).
139. Lowder CY, McMahon JT, Meisler DM et al. Microsporidial keratoconjunctivitis caused by Septata intestinalis in a patient with acquired immunodeficiency syndrome. Am. J. Ophthalmol. 121, 715-717 (1996).
140. Ingber D, Fujita T, Kishimoto S et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348, 555-557 (1990).
141. Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, Crews CM. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc. Natl. Acad. Sci. USA 94, 6099-6103 (1997).
142. Griffith EC, Su Z, Niwayama S, Ramsay CA, Chang YH, Liu JO. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Proc. Natl Acad. Sci. USA 95, 15183-15188 (1998).
143. Liu S, Widom J, Kemp CW, Crews CM, Clardy J. Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science. 282, 1324-1327 (1998).
144. Teicher BA, Holden SA, Ara G et al. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int. J. Cancer 57, 920-925 (1994).
145. Turk BE, Su Z, Liu JO. Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression. Bioorg. Med. Chem. 6(8), 1163-1169 (1998).
146. Bontems F, le Floch P, Duffieux F, Biderre C, Peyret P, Lallemand JY. Homology modeling and calculation of the cobalt cluster charges of the Encephalitozoon cuniculi methionine aminopeptidase, a potential target for drug design. Biophys. Chem. 105, 29-43 (2003).
147. Didier ES, Martin AD, Stovall ME et al. Methionine aminopeptidase 2 expression in microsporidia. J. Eukaryot. Microbiol. 50(Suppl.), 569-571 (2003).
148. Weiss LM, Zhou GC, Zhang H. Characterization of recombinant microsporidian methionine aminopeptidase type 2. J. Eukaryot. Microbiol. 50(Suppl.), 597-599 (2003).
149. Pandrea I, Mittleider D, Brindley PJ, Didier ES, Robertson DL. Phylogenetic relationships of methionine aminopeptidase type 2 among Encephalitozoon species and genotypes of microsporidia. Mol. Biochem. Parasitol. (2005) (In Press).
150. Benson CA, Kaplan JE, Masur H et al. Treating opportunistic infections among HIV-infected adults and adolescents. Morbid. Mortal. Weekly Rep. 53, 1-112 (2004).
151. Pozio E, Morales MA. The impact of HIV-protease inhibitors on opportunistic parasites. Trends Parasitol. 21, 58-63 (2005).
152. Goguel J, Katlama C, Sarfati C, Maslo C, Leport C, Molina JM. Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy. AIDS 11, 1658-1659 (1997).
153. Carr A, Marriott D, Field A, Vasak E, Cooper DA. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 351, 256-261 (1998).
154. Foudraine NA, Weverling GJ, van Gool T et al. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS 12, 35-41 (1998).
155. Miao YM, Awad-El-Kariem FM, Franzen C et al. Eradication of Cryptosporidia and microsporidia following successful antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 25, 124-129 (2000).
156. Lafaurie M, Sarfati C, Menotti J, Molina JM. Remission of disseminated infection caused by Encephalocytozoon intestinalis with highly active antiretroviral therapy. AIDS 17, 640-641 (2003).
157. Conners MS, Gibler TS, Van Gelder RN. Diagnosis of microsporidia keratitis by polymerase chain reaction. Arch. Ophthalmol. 122, 283-284 (2004).
158. Gajdatsy AD, Tay-Kearney ML. Microsporidial keratoconjunctivitis after HAART. Clin. Exp. Ophthalmol. 29, 327-329 (2001).
159. Martins SA, Muccioli C, Belfort R Jr, Castelo A. Resolution of microsporidial keratoconjunctivitis in an AIDS patient treated with highly active antiretroviral therapy. Am. J. Ophthalmol. 131, 378-379 (2001).
160. Anwar-Bruni DM, Hogan SE, Schwartz DA, Wilcox CM, Bryan RT, Lennox JL. Atovaquone is effective treatment for the symptoms of gastrointestinal microsporidiosis in HIV-1-infected patients. AIDS 10, 619-623 (1996).
161. Molina JM, Goguel J, Sarfati C et al. Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group. AIDS 11, 1603-1610 (1997).
162. Kester KE, Turiansky GW, McEvoy PL. Nodular cutaneous microsporidiosis in a patient with AIDS and successful treatment with long-term oral clindamycin therapy. Ann. Intern. Med. 128, 911-914 (1998).
163. Dionisio D, Sterrantino G, Meli M, Trotta M, Milo D, Leoncini F. Use of furazolidone for the treatment of microsporidiosis due to Enterocytozoon bieneusi in patients with AIDS. Recenti Prog. Med. 86, 394-397 (1995).
164. Dionisio D, Manneschi LI, Di Lollo S et al. Enterocytozoon bieneusi in AIDS: symptomatic relief and parasite changes after furazolidone. J. Clin. Pathol. 50, 472-476 (1997).
165. Dionisio D, Manneschi LI, Di Lollo S et al. Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients. J. Clin. Pathol. 51, 731-736 (1998).
166. Yee RW, Tio FO, Martinez JA, Held KS, Shadduck JA, Didier ES. Resolution of microsporidial epithelial keratopathy in a patient with AIDS. Ophthalmology 98, 196-201 (1991).
167. Albrecht H, Stellbrink HJ, Sobottka I. Failure of itraconazole to prevent Enterocytozoon bieneusi infection. Genitourin. Med. 71, 325-326 (1995).
168. Rossi P, Urbani C, Donelli G, Pozio E. Resolution of microsporidial sinusitis and keratoconjunctivitis by itraconazole treatment. Am. J. Ophthalmol. 127, 210-212 (1999).
169. Sridhar MS, Sharma S. Microsporidial keratoconjunctivitis in a HIV-seronegative patient treated with debridement and oral itraconazole. Am. J. Ophthalmol. 136, 745-746 (2003).
170. Leitch GJ, He Q, Wallace S, Visvesvara GS. Inhibition of the spore polar filament extrusion of the microsporidium, Encephalitozoon hellem, isolated from an AIDS patient. J. Eukaryot. Microbiol. 40, 711-717 (1993).
171. Canning EU, Hollister WS. Enterocytozoon bieneusi (Microspora): prevalence and pathogenicity in AIDS patients. Trans. R. Soc. Trop. Med. Hyg. 84, 181-186 (1990).
172. Eeftinck Schattenkerk JK, van Gool T, van Ketel RJ et al. Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals. Lancet 337, 895-898 (1991).
173. Sun T, Kaplan MH, Teichberg S, Weissman G, Smilari T, Urmacher C. Intestinal microsporidiosis. Report of five cases. Ann. Clin. Lab. Sci. 24, 521-532 (1994).
174. Brasil P, Sodre FC, Cuzzi-Maya T, Gutierrez MC, Mattos H, Moura H. Intestinal microsporidiosis in HIV-positive patients with chronic unexplained diarrhea in Rio de Janeiro, Brazil: diagnosis, clinical presentation and follow-up. Rev. Inst. Med. Trop. Sao
175. Gumbo T, Hobbs RE, Carlyn C, Hall G, Isada CM. Microsporidia infection in transplant patients. Transplantation 67, 482-484 (1999).
176. He Q, Leitch GJ, Visvesvara GS, Wallace S. Effects of nifedipine, metronidazole, and nitric oxide donors on spore germination and cell culture infection of the microsporidia Encephalitozoon hellem and Encephalitozoon intestinalis. Antimicrob. Agents Chemother. 40, 179-185 (1996).
177. White CA Jr. Nitazoxanide: a new broad spectrum antiparasitic agent. Expert Rev. Anti Infect. Ther. 2, 43-49 (2004).
178. Bicart-See A, Massip P, Linas MD, Datry A. Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS. Antimicrob. Agents Chemother. 44, 167-168 (2000).
179. Sharpstone D, Rowbottom A, Francis N et al. Thalidomide: a novel therapy for microsporidiosis. Gastroenterology 112, 1823-1829 (1997).
180. Ridoux O, Drancourt M. Lack of in vitro antimicrosporidian activity of thalidomide. Antimicrob. Agents Chemother. 43, 2305-2306 (1999).
181. 2+ influx. J. Cell. Biol. 100, 1834-1838 (1985).
182. Bigliardi E, Bernuzzi AM, Corona S, Gatti S, Scaglia M, Sacchi L. In vitro efficacy of nikkomycin Z against the human isolate of the microsporidian species Encephalitozoon hellem. Antimicrob. Agents Chemother. 44, 3012-3016 (2000).
183. Sobottka I, Bartscht K, Schafer P et al. In vitro activity of polyoxin D and nikkomycin Z against Encephalitozoon cuniculi. Parasitol. Res. 88(5), 451-453 (2002).
184. Ben-Ziony Y, Arzi B. Updated information for treatment of fungal infections in cats and dogs. J. Am. Vet. Med. Assoc. 218, 1718 (2001).
185. Mittleider D, Green LC, Mann VH, Michael SF, Didier ES, Brindley PJ. Genome survey sequences from the opportunistic microsporidian pathogen, Vittaforma corneae. J. Eukaryot. Microbiol. 49, 393-401 (2002).
186. Didier ES, Bowers L, Stovall ME et al. Antimicrosporidial activity of (fluoro)quinolones in vitro and in vivo. Folia Parasitol. 51, 1-9 (2005).
187. Chan CM, Theng JT, Li L, Tan DT. Microsporidial keratoconjunctivitis in healthy individuals: a case series. Ophthalmology 110, 1420-1425 (2003).
188. Bacchi CJ, Weiss LM. Chemotherapy of microsporidiosis: benzimidazoles, fumagillin, and polyamine analogues. In: Opportunistic Infections: Toxoplasma, Sarcocystis, and Microsporidia. Lindsay DS, Weiss LM (Eds), Kluwer Academic Publishers, NA, USA, 159-188 (2004).
189. Bacchi CJ, Weiss LM, Lane S et al. Novel synthetic polyamines are effective in the treatment of experimental microsporidiosis, an opportunistic AIDS-associated infection. Antimicrob. Agents Chemother. 46, 55-61 (2002).
190. Shadduck JA, Polley MB. Some factors influencing the in vitro infectivity and replication of Encephalitozoon cuniculi. J. Protozool. 25, 491-496 (1978).
191. Waller T. Sensitivity of Encephalitozoon cuniculi to various temperatures, disinfectants and drugs. Lab. Anim. 13, 227-230 (1979).
192. Santillana-Hayat M, Sarfati C, Fournier S et al. Effects of chemical and physical agents on viability and infectivity of Encephalitozoon intestinalis determined by cell culture and flow cytometry. Antimicrob. Agents Chemother. 46, 2049-2051 (2002).